论文信息 - An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma. - 字舞流文

An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma.

B. V. Van Tine | A. Hirbe | M. Milhem | S. Okuno | K. Kozak | M. Agulnik | S. Attia | S. Chawla | V. Monga | S. Robinson | A. Rademaker | B. Schulte | Hui Zhang | S. Abbinanti | R. Cehic